Search

Your search keyword '"Welling, D."' showing total 946 results

Search Constraints

Start Over You searched for: Author "Welling, D." Remove constraint Author: "Welling, D." Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
946 results on '"Welling, D."'

Search Results

1. Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2

4. Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2

5. Estimation of cold plasma outflow during geomagnetic storms

6. Contributors

9. A phase 1 trial of the histone deacetylase inhibitor AR-42 in patients with neurofibromatosis type 2-associated tumors and advanced solid malignancies

15. Systematic and other reviews: criteria and complexities

17. Identification of immune-related candidate biomarkers in plasma of patients with sporadic vestibular schwannoma

20. American Neurotology Society, American Otological Society, and American Academy of Otolaryngology – Head and Neck Foundation Guide to Enhance Otologic and Neurotologic Care During the COVID-19 Pandemic

24. Immune Profiling of Secreted Factors from Human Vestibular Schwannoma Cells and Tumor‐associated Macrophages.

26. Proton Radiotherapy for Vestibular Schwannomas in Patients with NF2-Related Schwannomatosis:A Case Series

27. Direct SARS-CoV-2 infection of the human inner ear may underlie COVID-19-associated audiovestibular dysfunction

29. Supplementary Figures 1-10, Table 1 from Histone Deacetylase Inhibitor AR-42 Differentially Affects Cell-cycle Transit in Meningeal and Meningioma Cells, Potently Inhibiting NF2-Deficient Meningioma Growth

30. Data from Histone Deacetylase Inhibitor AR-42 Differentially Affects Cell-cycle Transit in Meningeal and Meningioma Cells, Potently Inhibiting NF2-Deficient Meningioma Growth

31. Supplementary Methods, Figures Legends 1-10 from Histone Deacetylase Inhibitor AR-42 Differentially Affects Cell-cycle Transit in Meningeal and Meningioma Cells, Potently Inhibiting NF2-Deficient Meningioma Growth

42. Open Access: Is There a Predator at the Door?

43. Augmented Reality in Otology/Neurotology: A Scoping Review with Implications for Practice and Education.

46. Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2

47. 3D Modeling of Geomagnetically Induced Currents in Sweden-Validation and Extreme Event Analysis

48. Interhemispheric Asymmetry Due To IMF By Within the Cusp Spherical Elementary Currents.

50. Geomagnetically Induced Currents: Science, Engineering, and Applications Readiness

Catalog

Books, media, physical & digital resources